BFM
RLAY icon

Boothbay Fund Management’s Relay Therapeutics RLAY Stock Holding History

Boothbay Fund Management’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-137,841
Closed -$720K – 2293
2025
Q3 		$720K Sell
137,841
-85,146
-38% -$325K 0.01% 984
2025
Q2 		$772K Sell
222,987
-3,750
-2% -$11.2K 0.02% 769
2025
Q1 		$594K Buy
226,737
+12,338
+6% +$48.3K 0.02% 799
2024
Q4 		$883K Buy
214,399
+5,691
+3% +$31K 0.02% 681
2024
Q3 		$1.48M Buy
+208,708
New +$1.56M 0.03% 625

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Boothbay Fund Management's RLAY Position: Q4 2025 in Review

Boothbay Fund Management sold out of Relay Therapeutics (RLAY) in Q4 2025, closing a stake of 137,841 shares — an estimated $720K sold.

Boothbay Fund Management first reported a position in RLAY in Q3 2024 and held it in 5 quarters. The position peaked at $1.48M in Q3 2024. 227 funds tracked by Wall St. Rank hold RLAY as of Q4 2025.

  • Boothbay Fund Management reported no remaining Relay Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Boothbay Fund Management sold 137,841 Relay Therapeutics shares in Q4 2025, an estimated $720K.
  • Boothbay Fund Management first reported a position in Relay Therapeutics in Q3 2024 and held it in 5 quarters.
  • Boothbay Fund Management's Relay Therapeutics position peaked at $1.48M in Q3 2024.
  • 227 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2025.

Based on Boothbay Fund Management's 13F filing for Q4 2025, filed 17 Feb 2026.